Peer-reviewed journal articles (2)
  1. 1. Radwanska, M., de Lemos Esteves, F., Linsen, L., Coltel, N., Cencig, S., Widart, J. J., Massart, A., Colson, S., Di Paolo, A., Percier, P., Ait Djebbara, S., Guillonneau, F., Flamand, V., De Pauw, E., Frere, J.-L., Carlier, Y., & Truyens (Co-dernier auteur), C. (2023). Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice. Frontiers in immunology, 14, 1138526. doi:10.3389/fimmu.2023.1138526
  2. 2. Ait Djebbara, S., Mcheik, S., Percier, P., Segueni, N., Poncelet, P. A., & Truyens, C. (2023). The macrophage infectivity potentiator of Trypanosoma cruzi induces innate IFN-γ and TNF-α production by human neonatal and adult blood cells through TLR2/1 and TLR4. Frontiers in immunology, 14, 1180900. doi:10.3389/fimmu.2023.1180900
    3.   Theses and master's dissertations (1)
  3. 1. Ait Djebbara, S. (2021). Characterisation of the immuno-stimulatory effect of a Trypanosoma cruzi protein on human neonatal and adult blood cells (Unpublished doctoral dissertation). Université libre de Bruxelles, Faculté de Médecine – Sciences biomédicales et pharmaceutiques, Bruxelles.